Literature DB >> 32032101

Combined effects of mephedrone and cocaine on locomotor activity and conditioned place preference in male Sprague-Dawley rats.

Robert J Kohler1, Josefina Cibelli, Lisa E Baker.   

Abstract

Mephedrone (MEPH) is one of several synthetic cathinone derivatives and a common constituent of illicit 'bath salts'. Concomitant use of MEPH with other psychostimulants is common among recreational users, but their combined effects have not been evaluated rigorously. In experiment 1, 56 male Sprague-Dawley rats were administered saline, MEPH (1 or 5 mg/kg), COC (5 mg/kg), or a mixture of MEPH (1 or 5 mg/kg) + COC (5 mg/kg) for seven consecutive days. Following a 10-day drug washout, rats were given a challenge injection of COC (5 mg/kg). Locomotor activity was recorded for 60 minutes immediately before and for 60 minutes immediately after injections on days 1, 7, and 17. In experiment 2, an unbiased conditioned place preference procedure was implemented over a 10-day period with a separate group of 66 male Sprague-Dawley rats randomly assigned to similar drug treatments used in experiment. Results of experiment 1 indicated significant increases in horizontal activity after repeated treatment with MEPH+COC mixtures, but not with either drug alone. Additionally, rats pretreated with MEPH + COC mixtures exhibited an augmented response to cocaine following drug abstinence. Evidence for CPP was established in rats treated with 5 mg/kg MEPH, 5 mg/kg COC and the 5 mg/kg MEPH + 5 mg/kg COC mixture. In conclusion, cocaine and mephedrone may have additive locomotor stimulant effects, although further assessment with a wider range of dose combinations must be evaluated. As a precautionary note, concurrent use of these substances may pose an enhanced risk for abuse.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32032101      PMCID: PMC8817728          DOI: 10.1097/FBP.0000000000000539

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  31 in total

1.  The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.

Authors:  Michael H Baumann; Mario A Ayestas; John S Partilla; Jacqueline R Sink; Alexander T Shulgin; Paul F Daley; Simon D Brandt; Richard B Rothman; Arnold E Ruoho; Nicholas V Cozzi
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  6-Hydroxydopamine lesion of ventral pallidum blocks acquisition of place preference conditioning to cocaine.

Authors:  W Gong; D Neill; J B Justice
Journal:  Brain Res       Date:  1997-04-18       Impact factor: 3.252

3.  Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.

Authors:  Rong Chen; Michael R Tilley; Hua Wei; Fuwen Zhou; Fu-Ming Zhou; San Ching; Ning Quan; Robert L Stephens; Erik R Hill; Timothy Nottoli; Dawn D Han; Howard H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

4.  Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity.

Authors:  David M Wood; Susannah Davies; Malgorzata Puchnarewicz; Jenny Button; Roland Archer; Hanna Ovaska; John Ramsey; Terry Lee; David W Holt; Paul I Dargan
Journal:  J Med Toxicol       Date:  2010-09

5.  Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat.

Authors:  Sinead E Shortall; Alice E Macerola; Rabbi T R Swaby; Rebecca Jayson; Chantal Korsah; Katharine E Pillidge; Peter M Wigmore; Francis J P Ebling; A Richard Green; Kevin C F Fone; Madeleine V King
Journal:  Eur Neuropsychopharmacol       Date:  2012-10-07       Impact factor: 4.600

6.  Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.

Authors:  Candice Drouin; Gérard Blanc; Anne-Sophie Villégier; Jacques Glowinski; Jean-Pol Tassin
Journal:  Synapse       Date:  2002-01       Impact factor: 2.562

7.  Mephedrone exposure in adolescent rats alters the rewarding effect of morphine in adults.

Authors:  Listos Joanna; Talarek Sylwia; Gryzinska Magdalena; Listos Piotr; Kedzierska Ewa; Orzelska-Gorka Jolanta; Dylewska Malgorzata; Lupina Malgorzata; Jolanta H Kotlinska
Journal:  Eur J Pharmacol       Date:  2017-06-08       Impact factor: 4.432

8.  Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine.

Authors:  Karenza Moore; Paul I Dargan; David M Wood; Fiona Measham
Journal:  Eur Addict Res       Date:  2013-04-22       Impact factor: 3.015

9.  Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats.

Authors:  Shawn M Aarde; Deepshikha Angrish; Deborah J Barlow; M Jerry Wright; Sophia A Vandewater; Kevin M Creehan; Karen L Houseknecht; Tobin J Dickerson; Michael A Taffe
Journal:  Addict Biol       Date:  2013-01-30       Impact factor: 4.280

10.  Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.

Authors:  Krasnodara N Cameron; Renata Kolanos; Ernesto Solis; Richard A Glennon; Louis J De Felice
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

View more
  1 in total

1.  Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.

Authors:  Harmony I Risca; Julio D Zuarth-Gonzalez; Lisa E Baker
Journal:  Pharmacol Biochem Behav       Date:  2020-09-01       Impact factor: 3.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.